Diabetes News: FDA Approved Generic LGP-1 Meds
Before I begin, MEDICARE FOR ALL!! Now in spite of everything, the FDA is not completely insane, and…
Semaglutide (Wegovy) approved to treat form of liver disease
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (3 July 2026) approved a semaglutide injection (Wegovy)…
Follow safeguards to ensure your medications are safe and effective
Many people live longer and with better quality today because of the medications they take. But medications can…
Judge suspends Colorado’s price cap on prescription drug Embrel
DENVER — Colorado’s first attempt to cap the price of an unaffordable prescription drug has been blocked by…
Everything you need to know about GLP-1s for weight loss
Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as “breakthrough” drugs in 2023 — and their popularity has soared since. …
What Is Retatrutide? Benefits of the New Weight-Loss Drug Reta
What Is Retatrutide? Benefits of the New Weight-Loss Drug Reta Use left and right arrow keys to navigate…
China bans pet anaesthetic tiletamine after waves of young people vape drug
China has banned tiletamine, a common veterinary anaesthetic, after its recreational inhalation among young people escalated sharply. Since…
Pharmacist warns of heat risks for people on common medications
As hot temperatures pummel central Iowa, you may be more likely to experience heat-related side effects on certain…
Nearly 1 million bottles of heart, kidney medications recalled nationwide over ‘foreign substance’
Testing that raised concerns about possible foreign contamination has triggered a recall in the United States of nearly…
Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026
Revolution Medicines, Inc. REDWOOD CITY, Calif., July 02, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
Data incident prompts notices to patients of local radiology associate
AUGUSTA, Ga. (WRDW/WAGT) – In a letter mailed by MCBS, LLC, a company that provides billing support for…
Most ‘GLP-1 Nonresponders’ Never Get a Fair Shot
I see this pattern every week. A patient is 12 weeks into semaglutide therapy. They’ve lost 2%-3% of…